Taurus Asset Management, LLC Abbott Laboratories Transaction History

Taurus Asset Management, LLC

$944 Million
Q2 2024

A detailed history of Taurus Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Taurus Asset Management, LLC holds 10,827 shares of ABT stock, worth $1.27 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

10,827

Previous 12,047 10.13%

Holding current value

$1.27 Million

Previous $1.37 Million 17.82%

% of portfolio

0.12%

Previous 0.15%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$100.73 - $112.44 $122,890 - $137,176	-1,220 Reduced 10.13%	10,827 $1.13 Million
Q1 2024 May 08, 2024	SELL	$109.52 - $120.96 $89,806 - $99,187	-820 Reduced 6.37%	12,047 $1.37 Million
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $5,501 - $6,734	-61 Reduced 0.47%	12,867 $1.42 Million
Q2 2023 Aug 08, 2023	SELL	$100.78 - $112.29 $20,156 - $22,458	-200 Reduced 1.52%	12,928 $1.41 Million
Q1 2023 May 08, 2023	SELL	$96.86 - $114.01 $79,909 - $94,058	-825 Reduced 5.91%	13,128 $1.33 Million
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $193,352 - $226,831	-2,034 Reduced 12.72%	13,953 $1.53 Million
Q3 2022 Nov 09, 2022	SELL	$96.76 - $112.03 $128,207 - $148,439	-1,325 Reduced 7.65%	15,987 $1.55 Million
Q2 2022 Aug 10, 2022	SELL	$102.07 - $123.37 $113,501 - $137,187	-1,112 Reduced 6.04%	17,312 $1.88 Million
Q1 2022 May 09, 2022	SELL	$114.02 - $139.04 $91,216 - $111,232	-800 Reduced 4.16%	18,424 $2.18 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $196,401 - $240,482	-1,700 Reduced 8.12%	19,224 $2.71 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $189,572 - $209,722	-1,625 Reduced 7.21%	20,924 $2.47 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $116,369 - $136,983	-1,100 Reduced 4.65%	22,549 $2.61 Million
Q1 2021 May 12, 2021	SELL	$108.84 - $128.23 $48,216 - $56,805	-443 Reduced 1.84%	23,649 $2.83 Million
Q4 2020 Feb 09, 2021	SELL	$105.0 - $114.42 $99,750 - $108,699	-950 Reduced 3.79%	24,092 $2.64 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $3,573 - $4,340	-39 Reduced 0.16%	25,042 $2.73 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $15,773 - $20,188	-206 Reduced 0.81%	25,081 $2.29 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $73,687 - $107,751	-1,173 Reduced 4.43%	25,287 $2 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $15,702 - $17,480	-200 Reduced 0.75%	26,460 $2.3 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $6,301 - $6,832	-77 Reduced 0.29%	26,660 $2.23 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $2.51 Million - $2.93 Million	-34,450 Reduced 56.3%	26,737 $2.25 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $211,904 - $256,192	-3,200 Reduced 4.97%	61,187 $4.89 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $24,324 - $29,344	-400 Reduced 0.62%	64,387 $4.72 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $57,570 - $63,540	-1,000 Reduced 1.52%	64,787 $3.95 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $85,980 - $97,211	-1,528 Reduced 2.27%	65,787 $3.94 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $17,177 - $18,390	320 Added 0.48%	67,315 $3.84 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $3.22 Million - $3.59 Million	66,995	66,995 $3.58 Million

Others Institutions Holding ABT

# of Institutions

3,175

Shares Held

1.33B

Call Options Held

8.62M

Put Options Held

7.18M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Taurus Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Taurus Asset Management, LLC with notifications on news.

Account

Taurus Asset Management, LLC Abbott Laboratories Transaction History